Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
This is a defining moment for the company’s integrity, long-term viability, and moral compass. The core tension is between short-term financial protection and long-term trust, legal exposure, and—most importantly—patient safety. Ethically and legally, the company has a duty to act on credible safety signals.Read the full answer
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer